Oric Pharmaceuticals, Inc.
Company Stats
- Market Cap
- $1.4B
- as of Sep 30, 2026
- Shares Outstanding
- 103.7M
- Free Float
- 84.9%
Income Statement
- Operating Income
- -$143.0M
- Net Income
- -$129.5M
- EBITDA
- -$141.8M
Cash Flow
- Free Cash Flow
- -$111.7M
- FCF Yield
- -8.0%
- Owner FCF Yield
- -9.8%
Balance Sheet
- Cash & Equivalents
- $45.7M
Returns & Capital
- SBC, 3Y Avg
- $20.2M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | — | -$111.7M | — |
| FY2024 | — | -$113.8M | — |
| FY2023 | — | -$86.5M | — |
| FY2022 | — | -$77.2M | — |
| FY2021 | — | -$60.5M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of November 4, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges